132 results on '"Gladman, Dafna D"'
Search Results
2. A Hot Spot for Systemic Lupus Erythematosus, but Not for Psoriatic Arthritis, Identified by Spatial Analysis Suggests an Interaction Between Ethnicity and Place of Residence
3. Reduced Joint Counts Misclassify Patients With Oligoarticular Psoriatic Arthritis and Miss Significant Numbers of Patients With Active Disease
4. Lymphoma Risk in Systemic Lupus: Effects of Disease Activity Versus Treatment.: 2570
5. High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus
6. Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial
7. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus
8. International Multicenter Psoriasis and Psoriatic Arthritis Reliability Trial for the Assessment of Skin, Joints, Nails, and Dactylitis
9. Frequency and Determinants of Flare and Persistently Active Disease in Systemic Lupus Erythematosus
10. Systemic Lupus International Collaborating Clinics Renal Activity/Response Exercise: Development of a Renal Activity Score and Renal Response Index
11. Systemic Lupus International Collaborating Clinics Renal Activity/Response Exercise: Comparison of Agreement in Rating Renal Response
12. Association of interleukin-23 receptor variants with ankylosing spondylitis
13. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus
14. Prevalence of malignancy in psoriatic arthritis
15. Improved Survival in Psoriatic Arthritis With Calendar Time
16. A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time?
17. Adalimumab for Long-term Treatment of Psoriatic Arthritis: Forty-eight Week Data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial
18. Alefacept in Combination With Methotrexate for the Treatment of Psoriatic Arthritis: Results of a Randomized, Double-Blind, Placebo-Controlled Study
19. Association of the IL1 Gene Cluster With Susceptibility to Ankylosing Spondylitis: An Analysis of Three Canadian Populations
20. Adalimumab for the Treatment of Patients With Moderately to Severely Active Psoriatic Arthritis: Results of a Double-Blind, Randomized, Placebo-Controlled Trial
21. Description and Prediction of Physical Functional Disability in Psoriatic Arthritis: A Longitudinal Analysis Using a Markov Model Approach
22. The Effect of Pregnancy on Lupus Nephritis
23. Assessment of Patients With Psoriatic Arthritis: A Review of Currently Available Measures
24. Risk Factors for Coronary Heart Disease in Women With Systemic Lupus Erythematosus: The Toronto Risk Factor Study
25. The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: What has been changed?
26. Health-Related Quality of Life of Patients With Psoriatic Arthritis: A Comparison With Patients With Rheumatoid Arthritis
27. EXCESSIVE PATERNAL TRANSMISSION IN PSORIATIC ARTHRITIS
28. Immunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasis
29. Does early and aggressive treatment improve the prognosis in psoriatic arthritis? Comment on the article by Wong et al
30. MORTALITY STUDIES IN PSORIATIC ARTHRITIS: Results from a Single Outpatient Center. II. Prognostic Indicators for Death
31. MORTALITY STUDIES IN PSORIATIC ARTHRITIS: Results from a Single Outpatient Clinic. I. Causes and Risk of Death
32. The Reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in Patients with Systemic Lupus Erythematosus
33. Malignancy in Systemic Lupus Erythematosus
34. The Role of HLA Antigens as Indicators of Disease Progression in Psoriatic Arthritis: Multivariate Relative Risk Model
35. Quality of life over time in patients with systemic lupus erythematosus
36. Prevalence of malignancy in psoriatic arthritis
37. Association of theIL1 gene cluster with susceptibility to ankylosing spondylitis: An analysis of three Canadian populations
38. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: The role of patient nonadherence
39. Reply
40. Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region
41. Kidney biopsy in systemic lupus erythematosus
42. Lupus and pregnancy studies
43. Toward unraveling the mystery of psoriatic arthritis
44. Reply
45. Derivation of the sledai. A disease activity index for lupus patients
46. HLA antigens in north american patients with takayasu arteritis
47. The Protective Effect of Antimalarial Drugs on Thrombovascular Events in Systemic Lupus Erythematosus.
48. Kidney Biopsy in Systemic Lupus Erythematosus. II. Survival Analyses According to Biopsy Results
49. HLA–D region antigens in patients with rheumatoid arthritis
50. Impaired antigen-specific suppressor cell activity in patients with rheumatoid arthritis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.